How many email patterns does CuraSen Therapeutics, Inc. use?

CuraSen Therapeutics, Inc. uses 1 known email pattern.

What domain does CuraSen Therapeutics, Inc. use for work emails?

CuraSen Therapeutics, Inc. uses curasen.com for work email addresses.

Format	Example	Share of curasen.com
Last@curasen.comMost common	Doe@curasen.com	100%

Format

Example

Last@curasen.comMost common

Doe@curasen.com

Frequently Asked Questions

What does CuraSen Therapeutics, Inc. do?

CuraSen Therapeutics, Inc. was founded in 2017 and operates in the Biotechnology Research industry, alongside similar companies like Roche, Pfizer and Eli Lilly and Company. You can visit curasen.com. Explore CuraSen Therapeutics, Inc.'s company overview page for more information.

What is CuraSen Therapeutics, Inc.'s email address format?

CuraSen Therapeutics, Inc.'s email format typically follows the pattern of Last@curasen.com; this email format is used 100% of the time. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does CuraSen Therapeutics, Inc. have currently?

CuraSen Therapeutics, Inc. has approximately 20 employees as of November 2026. Key team members to contact include Chief Medical Officer: G. V., Chief Technical Officer: M. D. and Associate Director, Translational Science: R. M. For more team information and contact data, explore CuraSen Therapeutics, Inc.'s employee directory with LeadIQ.

CuraSen Therapeutics, Inc. Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

CuraSen Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in San Carlos, California, focused on developing novel treatments for neurodegenerative diseases, including Parkinson's and Alzheimer's, as well as orphan indications. The company pursues a therapeutic concept aimed at restoring a key functionality to a brain pathway emanating from the locus coeruleus, a region linked to early neurodegenerative pathology. It began evaluating its approach in 2019 by repurposing established drugs, which led to CST-2032 advancing into clinical testing in September 2020.

The organization describes its work as developing oral, rapid-onset small molecule therapies for neurodegenerative and psychiatric conditions, underpinned by neuroscience and pharmacology-focused clinical development. In October 2024, CuraSen appointed Kathleen Sereda Glaub as chief executive officer, marking a notable leadership update.

Most Common Email Formats at CuraSen Therapeutics, Inc.

@curasen.com

Need a specific person's email?

Frequently Asked Questions

What does CuraSen Therapeutics, Inc. do?

What is CuraSen Therapeutics, Inc.'s email address format?

How many employees does CuraSen Therapeutics, Inc. have currently?

CuraSen Therapeutics, Inc. Email Format

Ready to create more pipeline?

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Most Common Email Formats at CuraSen Therapeutics, Inc.

@curasen.com

Need a specific person's email?

Frequently Asked Questions

What does CuraSen Therapeutics, Inc. do?

What is CuraSen Therapeutics, Inc.'s email address format?

How many employees does CuraSen Therapeutics, Inc. have currently?

CuraSen Therapeutics, Inc. Email Format

Ready to create more pipeline?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Everything for prospecting,
in one platform.